Omnia Family Wealth’s State Street SPDR S&P Biotech ETF XBI Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q4
Sell
-87,600
Closed -$8.65M 84
2024
Q3
$8.65M Sell
87,600
-584
-0.7% -$57.4K 3.71% 6
2024
Q2
$8.18M Buy
+88,184
New +$7.91M 3.46% 6

Other funds holding XBI

Omnia Family Wealth's XBI Position: Q4 2024 in Review

Omnia Family Wealth sold out of State Street SPDR S&P Biotech ETF (XBI) in Q4 2024, closing a stake of 87,600 shares — an estimated $8.65M sold.

Omnia Family Wealth first reported a position in XBI in Q2 2024 and held it in 2 quarters. The position peaked at $8.65M in Q3 2024. 738 funds tracked by Wall St. Rank hold XBI as of Q4 2024.

  • Omnia Family Wealth reported no remaining State Street SPDR S&P Biotech ETF position as of Q4 2024 after selling out during the quarter.
  • Omnia Family Wealth sold 87,600 State Street SPDR S&P Biotech ETF shares in Q4 2024, an estimated $8.65M.
  • Omnia Family Wealth first reported a position in State Street SPDR S&P Biotech ETF in Q2 2024 and held it in 2 quarters.
  • Omnia Family Wealth's State Street SPDR S&P Biotech ETF position peaked at $8.65M in Q3 2024.
  • 738 funds tracked by Wall St. Rank held State Street SPDR S&P Biotech ETF as of Q4 2024.

Based on Omnia Family Wealth's 13F filing for Q4 2024, filed 6 Feb 2025.